This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Portfolio Pulse from Avi Kapoor
Several top Wall Street analysts have downgraded their ratings for major companies, including Baidu, BP, McKesson, Regeneron Pharmaceuticals, and First Horizon Corporation. These downgrades reflect a shift in analyst sentiment and could impact the stock prices of these companies in the short term.
September 24, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HSBC downgraded Baidu from Buy to Hold with a price target of $100. Baidu shares closed at $88.28, up 2.4%.
The downgrade from Buy to Hold by HSBC suggests a less optimistic outlook for Baidu, which could lead to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Redburn Atlantic downgraded BP from Buy to Neutral. BP shares closed at $32.86, up 0.7%.
The downgrade to Neutral indicates a more cautious stance on BP, which may result in a negative short-term impact on its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Wedbush downgraded First Horizon from Outperform to Neutral, slashing the price target from $20 to $17. Shares fell 1.9% to $15.67.
The downgrade and reduced price target suggest a less optimistic outlook for First Horizon, likely leading to a negative short-term impact on its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Baird downgraded McKesson from Outperform to Neutral, lowering the price target from $603 to $531. Shares fell 0.6% to $505.00.
The downgrade and reduced price target suggest a less favorable outlook for McKesson, likely leading to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Leerink Partners downgraded Regeneron from Outperform to Market Perform, cutting the price target from $1,175 to $1,077. Shares fell 4.6% to $1,091.98.
The downgrade and significant price target reduction indicate a more cautious view on Regeneron, likely causing a negative short-term impact on its stock price.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100